{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:15:47Z","timestamp":1787501747625,"version":"build-2736575974"},"reference-count":156,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The hepatitis C virus (HCV) is a major causative agent of hepatitis that may also lead to liver cancer and lymphomas. Chronic hepatitis C affects an estimated 2.4 million people in the USA alone. As the sole member of the genus Hepacivirus within the Flaviviridae family, HCV encodes a single-stranded positive-sense RNA genome that is translated into a single large polypeptide, which is then proteolytically processed to yield the individual viral proteins, all of which are necessary for optimal viral infection. However, cellular innate immunity, such as type-I interferon (IFN), promptly thwarts the replication of viruses and other pathogens, which forms the basis of the use of conjugated IFN-alpha in chronic hepatitis C management. As a countermeasure, HCV suppresses this form of immunity by enlisting diverse gene products, such as HCV protease(s), whose primary role is to process the large viral polyprotein into individual proteins of specific function. The exact number of HCV immune suppressors and the specificity and molecular mechanism of their action have remained unclear. Nonetheless, the evasion of host immunity promotes HCV pathogenesis, chronic infection, and carcinogenesis. Here, the known and putative HCV-encoded suppressors of innate immunity have been reviewed and analyzed, with a predominant emphasis on the molecular mechanisms. Clinically, the knowledge should aid in rational interventions and the management of HCV infection, particularly in chronic hepatitis.<\/jats:p>","DOI":"10.3390\/ijms242216100","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:42:08Z","timestamp":1699501328000},"page":"16100","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Suppression of Innate Immunity by the Hepatitis C Virus (HCV): Revisiting the Specificity of Host\u2013Virus Interactive Pathways"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1329-1786","authenticated-orcid":false,"given":"Sailen","family":"Barik","sequence":"first","affiliation":[{"name":"EonBio, 3780 Pelham Drive, Mobile, AL 36619, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: A systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000456580","article-title":"Lessons from epidemiology: The burden of liver disease","volume":"35","author":"Rowe","year":"2017","journal-title":"Dig. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/jvi.65.3.1105-1113.1991","article-title":"Structure and organization of the hepatitis C virus genome isolated from human carriers","volume":"65","author":"Takamizawa","year":"1991","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1478-3231.2011.02684.x","article-title":"An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region","volume":"32","author":"Nakano","year":"2012","journal-title":"Liver Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1073\/pnas.88.6.2451","article-title":"Genetic organization and diversity of the hepatitis C virus","volume":"88","author":"Choo","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/jvi.67.5.2832-2843.1993","article-title":"Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites","volume":"67","author":"Grakoui","year":"1993","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1128\/jvi.68.8.5045-5055.1994","article-title":"Kinetic and structural analyses of hepatitis C virus polyprotein processing","volume":"68","author":"Bartenschlager","year":"1994","journal-title":"J. Virol."},{"key":"ref_8","first-page":"9","article-title":"Processing pathways of the hepatitis C virus proteins","volume":"24","author":"Lohmann","year":"1996","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3851\/IMP2593","article-title":"Evolution of cell culture systems for HCV","volume":"18","author":"Taylor","year":"2013","journal-title":"Antivir. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JVI.02877-14","article-title":"Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77","volume":"89","author":"Li","year":"2015","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00430-018-0566-x","article-title":"Hepatitis C virus cell culture models: An encomium on basic research paving the road to therapy development","volume":"208","author":"Lohmann","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jir.2009.0063","article-title":"Intracellular innate immune cascades and interferon defenses that control hepatitis C virus","volume":"29","author":"Horner","year":"2009","journal-title":"J. Interferon. Cytokine Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1038\/s41598-023-33208-w","article-title":"Mechanisms of length-dependent recognition of viral double-stranded RNA by RIG-I","volume":"13","author":"Im","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000447947","article-title":"What really rigs up RIG-I?","volume":"8","author":"Barik","year":"2016","journal-title":"J. Innate. Immun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s13238-017-0431-5","article-title":"RIG-I: A multifunctional protein beyond a pattern recognition receptor","volume":"9","author":"Xu","year":"2018","journal-title":"Protein Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3389\/fimmu.2019.01586","article-title":"Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5","volume":"10","author":"Brisse","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3","volume":"122","author":"Seth","year":"2005","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1243","article-title":"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction","volume":"6","author":"Kawai","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1073\/pnas.0408707102","article-title":"Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling","volume":"102","author":"Foy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.molcel.2005.08.014","article-title":"VISA is an adapter protein required for virus-triggered IFN-beta signaling","volume":"19","author":"Xu","year":"2005","journal-title":"Mol. Cell."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1128\/JVI.01918-14","article-title":"MAVS coordination of antiviral innate immunity","volume":"89","author":"Vazquez","year":"2005","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.coviro.2011.11.001","article-title":"Induction and function of type I and III interferon in response to viral infection","volume":"1","author":"Levy","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1073\/pnas.0601523103","article-title":"Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection","volume":"103","author":"Loo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature07106","article-title":"Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA","volume":"454","author":"Saito","year":"2008","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/JVI.01796-07","article-title":"3\u2019 RNA elements in hepatitis C virus replication: Kissing partners and long poly(U)","volume":"82","author":"You","year":"2008","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","article-title":"An expanded lexicon for the ubiquitin code","volume":"24","author":"Dikic","year":"2023","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05732","article-title":"TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity","volume":"446","author":"Gack","year":"2007","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chom.2010.11.008","article-title":"The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection","volume":"8","author":"Oshiumi","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Oshiumi, H., Miyashita, M., Matsumoto, M., and Seya, T. (2013). A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003533"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1073\/pnas.1401674111","article-title":"Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity","volume":"111","author":"Kuniyoshi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1128\/JVI.01125-09","article-title":"Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells","volume":"83","author":"Wang","year":"2009","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.24763","article-title":"Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates","volume":"55","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Dansako, H., Yamane, D., Welsch, C., McGivern, D.R., Hu, F., Kato, N., and Lemon, S.M. (2013). Class A scavenger receptor 1 (MSR1) restricts hepatitis C virus replication by mediating toll-like receptor 3 recognition of viral RNAs produced in neighboring cells. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003345"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ni, G., Ma, Z., and Damania, B. (2018). cGAS and STING: At the intersection of DNA and RNA virus-sensing networks. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007148"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2008.09.003","article-title":"The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation","volume":"29","author":"Zhong","year":"2008","journal-title":"Immunity"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Aguirre, S., Luthra, P., Sanchez-Aparicio, M.T., Maestre, A.M., Patel, J., Lamothe, F., Fredericks, A.C., Tripathi, S., Zhu, T., and Pintado-Silva, J. (2017). Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. Nat. Microbiol., 2.","DOI":"10.1038\/nmicrobiol.2017.37"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"E2058","DOI":"10.1073\/pnas.1716937115","article-title":"STING-dependent translation inhibition restricts RNA virus replication","volume":"115","author":"Franz","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mib.2016.05.015","article-title":"Innate immune evasion strategies of DNA and RNA viruses","volume":"32","author":"Beachboard","year":"2016","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_47","first-page":"e25790","article-title":"STAT2 phosphorylation and signaling","volume":"2","author":"Steen","year":"2013","journal-title":"JAKSTAT"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Hu, Q., Bian, Q., Rong, D., Wang, L., Song, J., Huang, H.S., Zeng, J., Mei, J., and Wang, P.Y. (2023). JAK\/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Front. Bioeng. Biotechnol., 1.","DOI":"10.3389\/fbioe.2023.1110765"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and non-canonical aspects of JAK-STAT signaling: Lessons from interferons for cytokine responses","volume":"8","author":"Majoros","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3389\/fimmu.2017.01758","article-title":"Signaling activated by Type I interferons and viral antagonism","volume":"8","author":"Nan","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1073\/pnas.87.21.8555","article-title":"ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains","volume":"87","author":"Fu","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/j.1460-2075.1993.tb06106.x","article-title":"Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways","volume":"12","author":"Laxton","year":"1993","journal-title":"EMBO J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1101\/gad.4.10.1753","article-title":"Interferon-\u03b1 regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator","volume":"4","author":"Kessler","year":"1990","journal-title":"Genes Dev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/hep.20844","article-title":"Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector","volume":"42","author":"Helbig","year":"2005","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2893.2006.00732.x","article-title":"Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication","volume":"13","author":"Itsui","year":"2006","journal-title":"J. Viral. Hepat."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jhep.2011.07.026","article-title":"A functional genomic screen reveals novel host genes that mediate interferon-alpha\u2019s effects against hepatitis C virus","volume":"56","author":"Zhao","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/hep.25908","article-title":"Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication","volume":"56","author":"Metz","year":"2012","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"11145","DOI":"10.1128\/JVI.01551-16","article-title":"Identification of interferon-stimulated gene proteins that inhibit human parainfluenza virus type 3","volume":"90","author":"Rabbani","year":"2016","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000484258","article-title":"Interferon-stimulated genes as enhancers of antiviral innate immune signaling","volume":"10","author":"Crosse","year":"2018","journal-title":"J. Innate Immun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1128\/JVI.05633-11","article-title":"ISG56 and IFITM1 proteins inhibit hepatitis C virus replication","volume":"85","author":"Raychoudhuri","year":"2011","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1111\/j.1365-2893.2011.01452.x","article-title":"Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line","volume":"18","author":"Yao","year":"2011","journal-title":"J. Viral. Hepat."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhang, Y.-B., Liu, T.-K., and Gui, J.-F. (2013). Lineage-specific expansion of IFIT gene family: An insight into coevolution with IFN gene family. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066859"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26066","article-title":"IFITM1 is a tight junction protein that inhibits hepatitis C virus entry","volume":"57","author":"Wilkins","year":"2013","journal-title":"Hepatology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e00856-14","DOI":"10.1128\/mBio.00856-14","article-title":"Cell-type-specific effects of RNase L on viral induction of beta interferon","volume":"5","author":"Banerjee","year":"2014","journal-title":"mBio"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nature06042","article-title":"Small self-RNA generated by Rnase L amplifies antiviral innate immunity","volume":"448","author":"Malathi","year":"2007","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Cesaro, T., and Michiels, T. (2021). Inhibition of PKR by viruses. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.757238"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1053\/j.gastro.2013.02.026","article-title":"A genetic screen identifies interferon-\u03b1 effector genes required to suppress hepatitis C virus replication","volume":"144","author":"Fusco","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2000-9505","article-title":"Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome","volume":"20","author":"Alter","year":"2000","journal-title":"Semin. Liver Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.coviro.2016.09.010","article-title":"Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma","volume":"20","author":"Bandiera","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/088282402317340260","article-title":"To interfere and to anti-interfere: The interplay between hepatitis C virus and interferon","volume":"15","author":"He","year":"2002","journal-title":"Viral Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nature04078","article-title":"Evasion of intracellular host defence by hepatitis C virus","volume":"436","author":"Gale","year":"2005","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Tsuge, M., Fujimoto, Y., Hiraga, N., Zhang, Y., Ohnishi, M., Kohno, T., Abe, H., Miki, D., Imamura, M., and Takahashi, S. (2011). Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023856"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2893.1999.00152.x","article-title":"The NS3\/4A proteinase of the hepatitis C virus: Unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy","volume":"6","author":"Bartenschlager","year":"1999","journal-title":"J. Viral. Hepat."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1128\/jvi.67.7.4017-4026.1993","article-title":"NS3 is a serine protease required for processing of hepatitis C virus polyprotein","volume":"67","author":"Tomei","year":"1993","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/jvi.68.6.3753-3760.1994","article-title":"Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins","volume":"68","author":"Failla","year":"1994","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1128\/jvi.68.12.8147-8157.1994","article-title":"Hepatitis C virus NS3 serine proteinase: Trans-cleavage requirements and processing kinetics","volume":"68","author":"Lin","year":"1994","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1128\/jvi.69.4.2534-2539.1995","article-title":"NS3-4A of hepatitis C virus is a chymotrypsin-like protease","volume":"69","author":"Hahm","year":"1995","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1128\/jvi.69.12.7519-7528.1995","article-title":"Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation","volume":"69","author":"Bartenschlager","year":"1995","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/viro.1995.1229","article-title":"An in vitro assay for hepatitis C virus NS3 serine proteinase","volume":"209","author":"Bouffard","year":"1995","journal-title":"Virology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/jvi.69.1.198-205.1995","article-title":"Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase","volume":"69","author":"Bartenschlager","year":"1995","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1099\/0022-1317-77-5-1065","article-title":"A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease","volume":"77","author":"Tomei","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0969-2126(00)80025-8","article-title":"Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase","volume":"7","author":"Yao","year":"1999","journal-title":"Structure"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/135965359800303S01","article-title":"The hepatitis C virus NS3 proteinase: Structure and function of a zinc-containing serine proteinase","volume":"3","author":"Pessi","year":"1998","journal-title":"Antivir. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"17717","DOI":"10.1073\/pnas.0508531102","article-title":"Hepatitis C virus protease NS3\/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1128\/JVI.02495-05","article-title":"Dissociation of a MAVS\/IPS-1\/VISA\/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage","volume":"80","author":"Lin","year":"2006","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1743-422X-3-66","article-title":"Hepatitis C virus NS2 and NS3\/4A proteins are potent inhibitors of host cell cytokine\/chemokine gene expression","volume":"3","author":"Kaukinen","year":"2006","journal-title":"Virol. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"14590","DOI":"10.1073\/pnas.1110133108","article-title":"Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus","volume":"108","author":"Horner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"20483","DOI":"10.1074\/jbc.M500422200","article-title":"Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3\/4A protease","volume":"280","author":"Ferreon","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1111\/j.1742-4658.2007.05942.x","article-title":"Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes","volume":"274","author":"Dansako","year":"2007","journal-title":"FEBS J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"13862","DOI":"10.1074\/jbc.RA120.013898","article-title":"Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors","volume":"295","author":"Dultz","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1128\/jvi.68.11.7525-7533.1994","article-title":"Specificity of the hepatitis C virus NS3 serine protease: Effects of substitutions at the 3\/4A, 4A\/4B, 4B\/5A, and 5A\/5B cleavage sites on polyprotein processing","volume":"68","author":"Kolykhalov","year":"1994","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Abdullah, M.A.F., McWhirter, S.M., and Suo, Z. (2023). Modulation of kinase activities in vitro by hepatitis C virus protease NS3\/NS4A mediated-cleavage of key immune modulator kinases. Cells, 12.","DOI":"10.3390\/cells12030406"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jmv.23442","article-title":"Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKK\u03b5 and TBK1 functions","volume":"85","author":"Kaukinen","year":"2013","journal-title":"J. Med. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/viro.2002.1701","article-title":"Hepatitis C virus NS2 protein inhibits gene expression from different cellular and viral promoters in hepatic and nonhepatic cell lines","volume":"305","author":"Dumoulin","year":"2003","journal-title":"Virology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1073\/pnas.0810950106","article-title":"Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3","volume":"106","author":"Schregel","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nature04975","article-title":"Structure of the catalytic domain of the hepatitis C virus NS2-3 protease","volume":"442","author":"Lorenz","year":"2006","journal-title":"Nature"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Isken, O., Langerwisch, U., Jirasko, V., Rehders, D., Redecke, L., Ramanathan, H., Lindenbach, B.D., Bartenschlager, R., and Tautz, N. (2015). A conserved NS3 surface patch orchestrates NS2 protease stimulation, NS5A hyperphosphorylation and HCV genome replication. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004736"},{"key":"ref_101","first-page":"63","article-title":"The hepatitis C virus NS2\/3 protease","volume":"9","author":"Welbourn","year":"2007","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3390\/v2112481","article-title":"The future of HCV therapy: NS4B as an antiviral target","volume":"2","author":"Pang","year":"2010","journal-title":"Viruses"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jhep.2013.03.019","article-title":"Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity","volume":"59","author":"Ding","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.26017","article-title":"Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity","volume":"57","author":"Nitta","year":"2013","journal-title":"Hepatology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1128\/JVI.01720-15","article-title":"Hepatitis C virus NS4B can suppress STING accumulation to evade innate immune responses","volume":"90","author":"Yi","year":"2015","journal-title":"J. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"36417","DOI":"10.1074\/jbc.M508175200","article-title":"Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein","volume":"280","author":"Huang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2014.03.020","article-title":"Inhibition of hepatitis C virus infection by NS5A-specific aptamer","volume":"106","author":"Yu","year":"2014","journal-title":"Antiviral. Res."},{"key":"ref_108","unstructured":"Tan, S.L. (2006). Hepatitis C Viruses: Genomes and Molecular Biology, Horizon Bioscience."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199601113340203","article-title":"Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection","volume":"334","author":"Enomoto","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/MCB.18.9.5208","article-title":"Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation","volume":"18","author":"Gale","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.18632\/oncotarget.23562","article-title":"Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling","volume":"9","author":"Sugiyama","year":"2017","journal-title":"Oncotarget"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0168-8278(99)80255-4","article-title":"Long-term response to interferon alpha is unrelated to \u201cinterferon sensitivity determining region\u201d variability in patients with chronic hepatitis C virus-1b infection","volume":"30","author":"Squadrito","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0168-8278(99)80276-1","article-title":"suggested extension of the HCV ISDR does not alter our former conclusions on its predictive value for IFN response","volume":"30","author":"Rispeter","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1128\/JVI.00649-07","article-title":"Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88 dependent signaling pathway in macrophage cell lines","volume":"81","author":"Abe","year":"2007","journal-title":"J. Virol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e0170461","DOI":"10.1371\/journal.pone.0170461","article-title":"Nonstructural 5A protein of hepatitis C virus interferes with toll-like receptor signaling and suppresses the interferon response in mouse liver","volume":"12","author":"Tsutsumi","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"702","DOI":"10.14348\/molcells.2022.0018","article-title":"Hepatitis C virus nonstructural protein 5A interacts with immunomodulatory kinase IKK\u03b5 to negatively regulate innate antiviral immunity","volume":"45","author":"Kang","year":"2022","journal-title":"Mol. Cells"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2006.11.013","article-title":"HCV NS5A inhibits interferon-\u03b1 signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines","volume":"46","author":"Lan","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/JVI.00533-12","article-title":"Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling","volume":"86","author":"Kumthip","year":"2012","journal-title":"J. Virol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/viro.1997.8493","article-title":"Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein","volume":"230","author":"Gale","year":"1997","journal-title":"Virology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1128\/JVI.73.8.6506-6516.1999","article-title":"Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase","volume":"73","author":"Gale","year":"1999","journal-title":"J. Virol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/v4112598","article-title":"dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection","volume":"4","author":"Dabo","year":"2012","journal-title":"Viruses"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/viro.2002.1455","article-title":"Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines","volume":"297","author":"Koev","year":"2002","journal-title":"Virology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nsmb.1445","article-title":"Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2","volume":"15","author":"Terenin","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.antiviral.2009.05.004","article-title":"Translational insensitivity to potent activation of PKR by HCV IRES RNA","volume":"83","author":"Shimoike","year":"2009","journal-title":"Antiviral Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","article-title":"Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I","volume":"79","author":"Sumpter","year":"2005","journal-title":"J. Virol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2009.11.004","article-title":"Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation","volume":"6","author":"Garaigorta","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.virusres.2009.01.007","article-title":"PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control","volume":"142","author":"Kang","year":"2009","journal-title":"Virus Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/JVI.75.3.1401-1407.2001","article-title":"Hepatitis C virus NS5A physically associates with p53 and regulates p21\/waf1 gene expression in a p53-dependent manner","volume":"75","author":"Majumder","year":"2001","journal-title":"J. Virol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/JVI.79.5.3187-3194.2005","article-title":"Mutational analysis of hepatitis C virus nonstructural protein 5A: Potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain","volume":"79","author":"Appel","year":"2005","journal-title":"J. Virol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2007.01.042","article-title":"Phosphorylation of hepatitis C virus NS5A nonstructural protein: A new paradigm for phosphorylation-dependent viral RNA replication?","volume":"364","author":"Huang","year":"2007","journal-title":"Virology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e00194-17","DOI":"10.1128\/JVI.00194-17","article-title":"Serine 235 is the primary NS5A hyperphosphorylation site responsible for hepatitis C virus replication","volume":"91","author":"Hsu","year":"2017","journal-title":"J. Virol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e00737-18","DOI":"10.1128\/JVI.00737-18","article-title":"Characterization of a threonine-rich cluster in hepatitis C virus nonstructural protein 5A and its contribution to hyperphosphorylation","volume":"92","author":"Schenk","year":"2018","journal-title":"J. Virol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.00826-08","article-title":"Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles","volume":"82","author":"Masaki","year":"2008","journal-title":"J. Virol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Tellinghuisen, T.L., Foss, K.L., and Treadaway, J. (2008). Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000032"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e1000035","DOI":"10.1371\/journal.ppat.1000035","article-title":"Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly","volume":"4","author":"Appel","year":"2008","journal-title":"PLoS Pathog."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1099\/vir.0.009332-0","article-title":"Domain III of NS5A contributes to both RNA replication and assembly of hepatitis C virus particles","volume":"90","author":"Hughes","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Gawlik, K., Baugh, J., Chatterji, U., Lim, P.J., Bobardt, M.D., and Gallay, P.A. (2014). HCV core residues critical for infectivity are also involved in core-NS5A complex formation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088866"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2893.2000.00201.x","article-title":"Properties of the hepatitis C virus core protein: A structural protein that modulates cellular processes","volume":"7","author":"McLauchlan","year":"2000","journal-title":"J. Viral Hepat."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/viro.2000.0541","article-title":"The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line","volume":"276","author":"Hahn","year":"2000","journal-title":"Virology"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Chassey, B.de., Navratil, V., Tafforeau, L., Hiet, M.S., Aublin-Gex, A., Agaugu\u00e9, S., Meiffren, G., Pradezynski, F., Faria, B.F., and Chantier, T. (2008). Hepatitis C virus infection protein network. Mol. Syst. Biol., 4.","DOI":"10.1038\/msb.2008.66"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11262-015-1253-2","article-title":"Regulation of HepG2 cell apoptosis by hepatitis C virus (HCV) core protein via the sirt1-p53-bax pathway","volume":"51","author":"Feng","year":"2015","journal-title":"Virus Genes"},{"key":"ref_142","first-page":"7559","article-title":"Induction of Huh-7 cell apoptosis by HCV core proteins via CK1\u03b1-p53-Bid signaling pathway","volume":"17","author":"Shen","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Stone, A.E., Mitchell, A., Brownell, J., Miklin, D.J., Golden-Mason, L., Polyak, S.J., Gale, M.J., and Rosen, H.R. (2014). Hepatitis C virus core protein inhibits interferon production by a human plasmacytoid dendritic cell line and dysregulates interferon regulatory factor-7 and signal transducer and activator of transcription (STAT) 1 protein expression. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095627"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/JVI.01011-06","article-title":"Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes","volume":"81","author":"Ciccaglione","year":"2007","journal-title":"J. Virol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0168-1702(95)00034-N","article-title":"Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein","volume":"37","author":"Ray","year":"1995","journal-title":"Virus Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1074\/jbc.272.17.10983","article-title":"Transcriptional repression of p53 promoter by hepatitis C virus core protein","volume":"272","author":"Ray","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0378-1119(98)00030-4","article-title":"Hepatitis C virus core protein represses p21WAF1\/Cip1\/Sid1 promoter activity","volume":"208","author":"Ray","year":"1998","journal-title":"Gene"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0168-1702(01)00335-5","article-title":"The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation","volume":"79","author":"Jung","year":"2001","journal-title":"Virus Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1096\/fj.02-0664fje","article-title":"IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3","volume":"17","author":"Bode","year":"2003","journal-title":"FASEB J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2004.06.051","article-title":"SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA","volume":"320","author":"Vlotides","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12026-014-8494-3","article-title":"HCV core protein and virus assembly: What we know without structures","volume":"60","author":"Gawlik","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.virol.2014.04.018","article-title":"The elusive function of the Hepatitis C virus P7 protein","volume":"462\u2013463","author":"Atoom","year":"2014","journal-title":"Virology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/JVI.80.6.2913-2923.2006","article-title":"West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling","volume":"80","author":"Fredericksen","year":"2006","journal-title":"J. Virol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1128\/JVI.00226-08","article-title":"West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction","volume":"82","author":"Wilson","year":"2008","journal-title":"J. Virol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.virol.2010.05.020","article-title":"Nonstructural NS1 proteins of several mosquito-borne Flavivirus do not inhibit TLR3 signaling","volume":"404","author":"Baronti","year":"2010","journal-title":"Virology"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Majerov\u00e1, T., and Novotn\u00fd, P. (2021). Precursors of viral proteases as distinct drug targets. Viruses, 13.","DOI":"10.3390\/v13101981"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/22\/16100\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:19:36Z","timestamp":1760131176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/22\/16100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":156,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["ijms242216100"],"URL":"https:\/\/doi.org\/10.3390\/ijms242216100","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]}}}